Sound waves vs. cancer: large registry tracks HIFU outcomes

NCT ID NCT07645872

Recruiting now Knowledge-focused Sponsor: EDAP TMS S.A. Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This registry gathers real-world information from thousands of men treated with high-intensity focused ultrasound (HIFU) for prostate cancer using the Focal One device. The goal is to monitor safety and track cancer control through routine PSA tests and MRI scans. By collecting data from everyday medical practice, researchers hope to better understand how well this non-invasive treatment works outside of clinical trials.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: high-intensity focused ultrasound (HIFU)
What this could lead to: If the data show consistent safety and good cancer control, HIFU could become a standard, non-invasive option for treating prostate cancer.
What could go wrong: This is an observational registry, not a controlled trial, so it cannot prove cause and effect. Results depend on routine care and may vary across centers.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for PROSTATE CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

prostate cancer

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

PROSTATE CANCER

Contacts and locations

Locations

Clinique Nantes Atlantis
RECRUITING

Nantes, 44000, France
Clinique Saint vincent
RECRUITING

Besançon, 25056, France
Hôpital Civil Colmar
RECRUITING

Colmar, 68000, France
Hôpital Edouard Heriot
RECRUITING

Lyon, 69000, France
Hôpital privé Aix en provence
RECRUITING

Aix-en-Provence, 13080, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.